Please assess the completion status of the following clinical trial:

Trial Title: Effect of Pasireotide Long Acting Release (LAR) on Gonadotroph Adenomas

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* gonadotroph adenoma~Exclusion Criteria:~* visual impairment attributable to the adenoma~* radiation therapy~* active gallbladder disease~* uncontrolled diabetes

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Pasireotide LAR (Type: EXPERIMENTAL): 80 mg IM once monthly

Based on this trial design, predict the completion outcome and termination type (if applicable).